Morphic Announces Corporate Highlights and Second Quarter 2020 Financial Results
Company’s first IND accepted by FDA for MORF-057 in IBDPhase 1 study expected to begin in third-quarter 2020Positive data presented […]
Kamada Announces Enrollment of First Patient in its Phase 1/2 Clinical Trial of its Plasma-Derived Immunoglobulin (IgG) Product as a Potential Treatment for Coronavirus Disease (COVID-19) in Israel
Study Participants are Hospitalized, Non-ventilated COVID-19 Patients with Pneumonia Encouraging Neutralization Activity Observed with Virus Neutralization AssayPre-IND Meeting with U.S. FDA [...]
Voyager Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates
Plans to present three-year Phase 1b results […]
Galera Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Updates
Completed Enrollment of Randomized, Blinded, Placebo-controlled Trial of GC4419 in Combination with Radiotherapy in Locally Advanced Pancreatic Cancer; Topline Data […]
TSX News -
NXT Energy Solutions Announces Release Date for Its Second Quarter 2020 Results and Conference Call
CALGARY, Alberta, Aug. 10, 2020 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX:SFD; OTC QB:NSFDF) announces […]
TSX News -
Corvus Gold to Trade on the Nasdaq, Obtains Full Senior US Listing Under Symbol KOR
VANCOUVER, British Columbia, Aug. 10, 2020 (GLOBE NEWSWIRE) — Corvus Gold Inc. (“Corvus” or the “Company”) – (TSX: KOR, OTCQX: […]
Emerita Resources Provides Update on Drill Permitting and Drill Hole Data Base Progress at Paymogo Project, Spain
TORONTO, Aug. 10, 2020 (GLOBE NEWSWIRE) — Emerita Resources Corp. (TSX-V: EMO) (the “Company” or “Emerita”) announces it has engaged […]
New Pacific Announces Graduation to TSX
VANCOUVER, British Columbia, Aug. 10, 2020 (GLOBE NEWSWIRE) — New Pacific Metals Corp. (TSX-V: NUAG) (OTCQX: NUPMF) (“New Pacific” or […]
Exterran Corporation Announces Second Quarter 2020 Results
Strong Operational Performance despite Challenging EnvironmentCompany to Exit the U.S. Compression Fabrication Business in the Fourth QuarterHOUSTON, Aug. 10, 2020 […]
Intercept Pharmaceuticals Reports Second Quarter 2020 Financial Results, Announces Updates to Financial Guidance and Provides Business Update
Worldwide Ocaliva net sales of $77.2 million in the second quarter 2020, representing 17% growth over the prior year quarter Intercept […]
